Biotech Values

[mcbio]

Re: Oral RA/Autoimmune Drugs (SNTA)

I just found out that SNTA has an oral RA drug in Phase 2a trials called apilimod, with results due by the end of this year. This is an oral IL-12/IL-23 inhibitor. However, I listened to the 5/18/09 Deutsche Bank conference webcast and the presenter effectively said that they have obeserved some "pharmaceutical properties that are not optimized" so I guess that means you can pretty much scratch that one.